Ginkgo Bioworks Holdings Inc (DNA)
0.4087
-0.01
(-2.92%)
USD |
NYSE |
Jun 20, 16:00
0.4008
-0.01
(-1.93%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Free Cash Flow: -322.24M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -322.24M |
| December 31, 2023 | -336.30M |
| September 30, 2023 | -405.20M |
| June 30, 2023 | -369.10M |
| March 31, 2023 | -391.02M |
| Date | Value |
|---|---|
| December 31, 2022 | -304.47M |
| September 30, 2022 | -344.95M |
| June 30, 2022 | -313.79M |
| March 31, 2022 | -263.75M |
| December 31, 2021 | -310.34M |
Free Cash Flow Range, Past 5 Years
-405.20M
Minimum
Sep 2023
-263.75M
Maximum
Mar 2022
-336.12M
Average
-329.27M
Median
Free Cash Flow Benchmarks
| Pacific Biosciences of California Inc | -249.16M |
| Teladoc Health Inc | 199.55M |
| Prime Medicine Inc | -200.61M |
| Inovio Pharmaceuticals Inc | -116.52M |
| Nektar Therapeutics | -189.17M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -89.26M |
| Cash from Investing (Quarterly) | -12.11M |
| Cash from Financing (Quarterly) | -0.845M |
| Free Cash Flow Per Share (Quarterly) | -0.0479 |
| Free Cash Flow to Equity (Quarterly) | -95.97M |
| Free Cash Flow to Firm (Quarterly) | -95.97M |
| Free Cash Flow Yield | -40.09% |